William Christian, MD
Cornea and External Diseases Specialist · Santa Monica, CANPI 1285825158
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,988 of the $32,686 with a category attached, or 70.3%. Johnson & Johnson Surgical Vision, Inc. accounts for 90.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $28,831 and has fallen 89.5% since, to $3,019 in 2025.
Across 38 payments — averaging $860.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$30K
- Optos, Inc.$2K
- Glaukos Corporation$1K
- Carl Zeiss Meditec USA, Inc.$115
- Novartis$91
- AbbVie$69
- plus $53 from 2 others
What the payments were for
- Consulting fees$22,98870%
- Speaking & faculty fees$5,50017%
- Travel & lodging$2,7869%
- Food & beverage$1,3234%
- Gifts$390%
- Entertainment$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 21 | $29,661 |
| Optos, Inc. | 4 | $1,575 |
| Glaukos Corporation | 3 | $1,123 |
| Carl Zeiss Meditec USA, Inc. | 1 | $115 |
| Novartis | 2 | $91 |
| AbbVie(2 entities) | 4 | $69 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Biotissue Holdings Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis Symfony IOL$24,108
- Tecnis Multifocal Family of 1-piece IOLS$22,313
- Tecnis Toric 1-piece IOL$3,306
- Tecnis IOL$3,111
- CATALYS SYSTEM$1,566
- PANORAMIC OPHTHALMOSCOPE$1,500
- OCT OPHTHALMOSCOPE$1,500
- Tecnis 1-piece IOL$760
- Tecnis Symphony IOL$185
- Tecnis Symphony Toric IOL$185
- ARTEVO 800$115
How this compares
$32,686 in reported general payments places this provider in the 80th percentile of 50 cornea and external diseases specialist providers in California.
See all cornea and external diseases specialist providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 133 | $67,657 |
| RestasisCyclosporine | 12 | $14,026 |
| Brinzolamide | 39 | $10,088 |
| Prednisolone Acetate | 152 | $7,626 |
| Cyclosporine | 18 | $5,923 |
| Brimonidine Tartrate | 50 | $5,839 |
| AzoptBrinzolamide | 13 | $5,571 |
| Bromfenac Sodium | 50 | $5,443 |
| Travoprost | 24 | $3,976 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 12 | $3,096 |
| Gatifloxacin | 65 | $2,768 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 147 | $2,761 |
| Latanoprost | 228 | $2,131 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 34 | $1,949 |
| Dorzolamide Hcl | 61 | $1,312 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Restasis | $69 | $81,683145 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 50 cornea and external diseases specialist providers in California.
Other cornea and external diseases specialist in Santa Monica
- Kathryn GardnerSanta Monica$35
- Sumit GargIrvine$808K
- Jillian ChongBeverly Hills$113K
- Tyson KimSan Francisco$91K
- Edward MancheStanford$78K
- Michael SavetskyCulver City$63K
- Michael SaidelSonoma$51K
- Matthew WadeIrvine$38K
- Lawrence ChaoIrvine$36K
- Alexander FosterEncinitas$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.